Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,373 | 36,567 | 36,469 | 45,225 | 22,521 |
| Marketable Securities | 26,954 | 36,245 | 56,028 | 50,701 | 75,557 |
| Receivables | 15,973 | 14,631 | 11,727 | 9,660 | 10,111 |
| Inventories | 1,638 | 2,050 | 1,684 | 1,622 | 1,354 |
| TOTAL | $88,983 | $99,848 | $113,090 | $116,332 | $119,005 |
| Non-Current Assets | |||||
| PPE Net | 2,676 | 2,517 | 2,381 | 2,595 | 2,159 |
| Other Non-Current Assets | 18,719 | 20,693 | 22,564 | 24,436 | 26,405 |
| TOTAL | $21,395 | $23,210 | $24,945 | $27,031 | $28,564 |
| Total Assets | $110,378 | $123,058 | $138,035 | $143,363 | $147,569 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,707 | 2,283 | 3,414 | 2,207 | 4,152 |
| Accrued Expenses | 14,481 | 11,469 | 12,440 | 12,202 | 14,779 |
| TOTAL | $40,841 | $34,192 | $34,760 | $31,172 | $58,212 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,815 | 19,836 | 19,816 | 9,829 | 9,810 |
| Deferred Revenues | 3,018 | 3,069 | 3,215 | 2,053 | 25,288 |
| Other Non-Current Liabilities | 15,696 | 17,929 | 20,249 | 22,305 | 24,328 |
| TOTAL | $35,511 | $37,911 | $40,065 | $33,692 | $35,542 |
| Total Liabilities | $76,352 | $72,103 | $74,825 | $64,864 | $93,754 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,004 | 16,898 | 16,893 | 16,857 | 16,857 |
| Common Shares | 169 | 169 | 169 | 169 | 168 |
| Retained earnings | -1,305,972 | -1,286,735 | -1,272,561 | -1,254,985 | -1,276,228 |
| Other shareholders' equity | -4 | 2 | 46 | 78 | 23 |
| TOTAL | $34,026 | $50,955 | $63,210 | $78,499 | $53,815 |
| Total Liabilities And Equity | $110,378 | $123,058 | $138,035 | $143,363 | $147,569 |